28 State AGs Ask FDA to Reconsider Approval of Zohydro ER Because of Abuse Potential (FREE)

By Kelly Young Twenty-eight state attorneys general have asked the FDA to reconsider its approval of Zohydro ER, a hydrocodone-only painkiller, or consider an expedited schedule for developing an abuse-deterrent version. In …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news